Prednisone
Drugoral administration, 60mg/d for 10d
NCT Number: NCT05024448
The vestibular system is a part of the inner ear and functions as a motion sensor. It provides the central nervous system with information about changes of the head position. This information is essential for the proper functioning of the balance system. In particular, it ensures effective postural control and gaze stabilization. Abrupt vestibular deficit is defined as a sudden loss of the vestibular function. In the acute phase the patient presents mainly with intense rotatory vertigo and instability, most often accompanied by nausea. The symptoms are exacerbated by head movements. The diagnosis is made by observation of a spontaneous nystagmus, measurement of a pathological head impulse test and an asymmetric response to caloric tests, in the absence of other neurological symptoms. Although the etiology is unknown, it could be of viral or vascular origin. Symptoms usually regress within a few days or weeks. Vestibular function recovers in about half of the cases, in the other half a central compensation process is set up. The benefit of a 3-week course of corticosteroids has been demonstrated in one study. The dosage has been debated. The aim of this study is to demonstrate the benefit of a 10-day course of oral corticosteroids. The primary objective is to demonstrate a significant reduction in the rate of asymmetry of caloric response and the secondary objective is to demonstrate a significant reduction in the impact of symptoms assessed with the Dizziness Handicap Inventory (DHI) score at 1 year.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Medical History :
Physical examination :
Exclusion criteria
oral administration, 60mg/d for 10d
Time frame: Day 1
Time frame: Day 21
Time frame: Day 365
Time frame: Day 1, Day 21, Day 365
min: 0 / max:100, higher score is worse
University Hospital, Geneva
Other
Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy, a Multicentric, Randomized, Double-blind, Placebo-controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02483429
Benign Paroxysmal Positional Vertigo, Brain Diseases
Peoria, Illinois, United States
View Trial DetailsNCT03846830
Brain Concussion, Brain Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT04869020
Cranial Nerve Diseases, Ear Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT02655575
Bronchial Diseases, Bronchiolitis
Bergen, Norway
View Trial Details